232:
238:
162:
A provisional application for patent provides more benefits and protections to inventors than a disclosure document and can be used for the same purposes as a disclosure document if necessary. ... A non-provisional application must be filed within twelve months of the filing date of a provisional
153:
The
Disclosure Document Program (DDP) was a USPTO program that allowed an inventor to file a preliminary description of his/her invention. The program was discontinued by the USPTO as of February 1, 2007, in favor of filing a
104:§2138.04 "Conception" ). "In some instances, such as the discovery of genes or chemicals, an inventor is unable to establish a conception until he has reduced the invention to practice through a successful experiment."
64:
55:
Conception is the "formation in the mind of the inventor, of a definite and permanent idea of the complete and operative invention, as it is hereafter to be applied in practice."
28:
beyond the conception thereof. Reduction to practice may be either actual (the invention is actually carried out and is found to work for its intended purpose) or constructive (a
100:"Simultaneous conception and reduction to practice": "On rare occasions conception and reduction to practice occur simultaneously in unpredictable technologies." (citing
281:
101:
300:
305:
274:
49:
33:
247:
17:
89:
Constructive reduction to practice: "ccurs upon the filing of a patent application on the claimed invention."
155:
41:
142:
267:
36:
is filed). The date of reduction to practice was critical to the determination of priority between
202:
191:
78:
Actual reduction to practice: "equires that the claimed invention work for its intended purpose."
29:
120:(Fed. Cir. 1991)). The court will apply this doctrine in so-called "unpredictable arts" such as
251:
231:
145:, several additional kinds of evidence can be used to establish an earlier priority date.
45:
163:
patent in order for the inventor to claim the benefit of the provisional application. ...
180:
294:
128:
where the invention is a "biologically active composition of matter," also called a "
117:
109:
94:
83:
60:
213:
129:
125:
25:
37:
121:
106:
The
Regents of the University of California v. Synbiotics Co.
74:
The reduction to practice of an invention can either be:
255:
114:Amgen, Inc. v. Chugai Pharmaceutical Co., Ltd.
275:
57:Hybritech Inc. v. Monoclonal Antibodies, Inc.
8:
282:
268:
173:
250:or its constituent jurisdictions is a
7:
227:
225:
24:is the step in the formation of an
254:. You can help Knowledge (XXG) by
14:
236:
230:
1:
149:Disclosure Document Program
50:swearing behind a reference
322:
224:
67:1986) (quoting 1 Robinson
246:This article relating to
112:(S.D.Cal., 1994) (citing
301:United States patent law
248:law in the United States
18:United States patent law
306:United States law stubs
156:provisional application
91:Brunswick Corp. v. U.S.
80:Brunswick Corp. v. U.S.
44:under the discontinued
42:interference proceeding
165:
137:Some types of evidence
48:system as well as for
160:
34:sufficient disclosure
22:reduction to practice
110:849 F.Supp. 740, 742
95:34 Fed. Cl. 532, 584
84:34 Fed. Cl. 532, 584
158:. The USPTO says:
143:inventor's notebook
118:927 F.2d 1200, 1206
61:802 F.2d 1367, 1376
52:under that system.
141:In addition to an
30:patent application
263:
262:
313:
284:
277:
270:
242:
241:
240:
239:
234:
226:
216:
211:
205:
200:
194:
189:
183:
178:
321:
320:
316:
315:
314:
312:
311:
310:
291:
290:
289:
288:
237:
235:
229:
222:
220:
219:
212:
208:
201:
197:
190:
186:
179:
175:
170:
151:
139:
46:first-to-invent
12:
11:
5:
319:
317:
309:
308:
303:
293:
292:
287:
286:
279:
272:
264:
261:
260:
243:
218:
217:
206:
203:MPEP § 2138.04
195:
192:MPEP § 2138.05
184:
172:
171:
169:
166:
150:
147:
138:
135:
134:
133:
98:
87:
13:
10:
9:
6:
4:
3:
2:
318:
307:
304:
302:
299:
298:
296:
285:
280:
278:
273:
271:
266:
265:
259:
257:
253:
249:
244:
233:
228:
223:
215:
214:USPTO Website
210:
207:
204:
199:
196:
193:
188:
185:
182:
177:
174:
167:
164:
159:
157:
148:
146:
144:
136:
131:
127:
123:
119:
115:
111:
107:
103:
99:
96:
92:
88:
85:
81:
77:
76:
75:
72:
70:
66:
62:
58:
53:
51:
47:
43:
39:
35:
31:
27:
23:
19:
256:expanding it
245:
221:
209:
198:
187:
176:
161:
152:
140:
130:bio-chemical
113:
105:
90:
79:
73:
71:532 (1890).
68:
56:
54:
21:
15:
132:substance."
295:Categories
181:MPEP § 715
168:References
69:On Patents
126:chemistry
65:Fed. Cir.
38:inventors
32:having a
26:invention
122:biology
97:(1995).
86:(1995).
40:in an
20:, the
252:stub
124:and
102:MPEP
16:In
297::
116:,
108:,
93:,
82:,
59:,
283:e
276:t
269:v
258:.
63:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
